Trial Profile
Effects of bevacizumab on microvessel density and endothelial cell proliferation levels in patients with colorectal liver metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 29 Jun 2016 New trial record